Sensient Technologies Corporation logo SXT - Sensient Technologies Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 4
SELL 0
STRONG
SELL
0
| PRICE TARGET: $140.00 DETAILS
HIGH: $155.00
LOW: $125.00
MEDIAN: $140.00
CONSENSUS: $140.00
UPSIDE: 5.74%

Stock News

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

TAIZHOU, China, Aug. 05, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (the “Company”), today announced that it will effect a share consolidation of its Class A ordinary shares, no par value per share, and Class B ordinary shares no par value per share, at a ratio of 1-for-80, effective on August 10, 2026 (the “Share Consolidation”). The Company's Class A ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on August 10, 2026.

Aug 05, 2026 05:00 AM globenewswire.com
ADAR1 Capital Management LLC Takes Position in Sensient Technologies Corporation $SXT

ADAR1 Capital Management LLC Takes Position in Sensient Technologies Corporation $SXT

ADAR1 Capital Management LLC acquired a new position in Sensient Technologies Corporation (NYSE: SXT) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 15,000 shares of the specialty chemicals company's stock, valued at approximately $1,297,000. Other large investors have also made changes

Jul 28, 2026 11:45 PM defenseworld.net
California Public Employees Retirement System Trims Position in Sensient Technologies Corporation $SXT

California Public Employees Retirement System Trims Position in Sensient Technologies Corporation $SXT

California Public Employees Retirement System reduced its holdings in Sensient Technologies Corporation (NYSE: SXT) by 22.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 56,365 shares of the specialty chemicals company's stock after selling 16,344 shares during the period. California Public

Jul 27, 2026 12:45 AM defenseworld.net
Sensient Technologies Q2 Earnings Call Highlights

Sensient Technologies Q2 Earnings Call Highlights

Sensient Technologies (NYSE: SXT) reported second-quarter 2026 results marked by double-digit local-currency growth in revenue, adjusted EBITDA and adjusted earnings per share, as demand for natural color conversions continued to build ahead of U.S. regulatory deadlines. Chairman, President and Chief Executive Officer Paul Manning said the company delivered 10% local-currency revenue growth, 21% local-currency adjusted EBITDA

Jul 25, 2026 10:03 PM defenseworld.net
Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2026

Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2026

MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT), a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, today reported financial results for the second quarter ended June 30, 2026. Second Quarter Consolidated Results Reported revenue increased 11.6% to $462.1 million in the second quarter of 2026 versus last year's second quarter results of $414.2 million. On a local currency basis(1), revenue increased 9.9%. Reported operatin.

Jul 24, 2026 02:55 AM businesswire.com
Sensient Declares Dividend

Sensient Declares Dividend

MILWAUKEE--(BUSINESS WIRE)--The Board of Directors of Sensient Technologies Corporation (NYSE: SXT) has declared a regular quarterly cash dividend on its common stock of $0.41 per share. The cash dividend will be paid on September 1, 2026, to shareholders of record on August 3, 2026. About Sensient Technologies Sensient Technologies Corporation is a leading global manufacturer and marketer of colors, flavors, and other specialty ingredients. Sensient uses advanced technologies and robust global.

Jul 23, 2026 02:38 PM businesswire.com
China SXT Pharmaceuticals Inc. Announces $9 Million Registered Direct Offering

China SXT Pharmaceuticals Inc. Announces $9 Million Registered Direct Offering

TAIZHOU, China, July 23, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the “Company”), today announced that it has entered into a definitive securities purchase agreement with certain institutional investors for the purchase and sale of an aggregate of 4,500,000 units (each, a “Unit”), consisting of one Class A ordinary share of the Company, no par value per share (each, a “Class A ordinary share”), and one common warrant (each, a “Warrant”), at a purchase price of $2.00 per Unit in a registered direct offering.

Jul 23, 2026 04:45 AM globenewswire.com
Sensient Announces Conference Call

Sensient Announces Conference Call

MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT) will hold its earnings call and webcast to discuss 2026 second quarter results at 8:30 a.m. CDT on Friday, July 24, 2026. Investors may access the live webcast on the Company's web site at investor.sensient.com. Alternatively, investors may join the conference call by contacting Chorus Call Inc. at (844) 492-3726 or (412) 317-1078.A webcast replay will be available on the Company's web site following the call. The call tra.

Jul 10, 2026 12:29 PM businesswire.com

Price Targets